FMR1 and fragile X syndrome: Although Fmr1 KO mice have been the leading model, Fmr1 KO rats offer additional translational validity for elucidating the neurobiological substrate of FXS and the efficacy of novel pharmacological interventions, due to their pronounced behavioral and neurobiological complexity [9].